Cosdosiran sodium is a chemically modified siRNA designed to temporarily inhibit expression of the caspase 2 protein and can be used for the study of nonarteritic anterior ischemic optic neuropathy and other optic neuropathies such as glaucoma that result in the death of retinal ganglion cells.
Smiles
[Cosdosiran(sodium)]
Target
Caspase; Small Interfering RNA (siRNA)
Purity
98.48
Solubility
H2O : ≥ 50 mg/mL
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)